Advertisement

Medical Oncology

, 36:100 | Cite as

Correction to: Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis

  • Shruti BhandariEmail author
  • Rohit Kumar
  • Prashant Tripathi
  • Abigail Chan
  • Sarah Mudra
  • Rebecca Redman
Correction
  • 72 Downloads

Correction to: Medical Oncology (2019) 36:90  https://doi.org/10.1007/s12032-019-1315-8

The original version of this article contains an error in the Tables 1 and 2. The correct version of Tables 1 and 2 were given below.
Table 1

Patient demographic and clinical characteristics

 

No hypercalcemia

Hypercalcemia

P value

n = 7,374,334

n = 126,875

 

Age, mean (years)

65.7

65.7

0.95

Female (%)

48.9

49.3

0.26

Race (%)

  

< 0.001

White

73.1

68.7

 

Black

12.9

19.6

 

Hispanic

7.8

6.7

 

Other

6.1

5

 

Insurance (%)

  

< 0.001

Medicare

55.6

54.8

 

Medicaid

10.2

14.4

 

Private

28.9

24.5

 

Other/self-pay

5.3

6.3

 

Total number of comorbidities, mean

4.8

6

< 0.001

Hospital setting (%)

  

< 0.001

Rural

8.3

9.1

 

Urban non-teaching

27.6

29.8

 

Urban teaching

64

61.1

 

Hospital region (%)

  

< 0.001

Northeast

21.1

20.2

 

Midwest

22.9

22.8

 

South

37.6

39.6

 

West

18.5

17.4

 

Type of cancer (%)

Lung

19.3

29.5

< 0.001

Breast

8.7

10.3

< 0.001

Colorectal/anal

11.7

3.8

< 0.001

Prostate

9.6

3.9

< 0.001

Head and neck

3.8

5.2

< 0.001

Pancreatic

4.4

2.8

< 0.001

Esophagus/gastric

3.6

2.7

< 0.001

Liver/biliary tract

3.4

3

< 0.001

Bone/connective tissue

1.9

1.3

< 0.001

Melanoma

0.9

0.6

< 0.001

Kidney/bladder

7.9

10.2

< 0.001

Central nervous system

2.7

0.6

< 0.001

Male genital

0.4

0.4

0.387

Female genital

6.6

4.8

< 0.001

Other

16.9

22.8

< 0.001

Metastatic cancer (%)

44

73.3

< 0.001

Mechanical ventilation use (%)

3.6

4.7

< 0.001

Renal disease (%)

10.5

14

< 0.001

Inpatient chemotherapy (%)

3.8

4.8

< 0.001

Palliative consult (%)

8.7

21.7

< 0.001

Protein calorie malnutrition (%)

9.3

19.7

< 0.001

Total hospital charge (US dollars)

  

< 0.001

≤ 49K

63.7

61.4

 

50–99K

22.1

22.4

 

≥ 100K

14.2

16.2

 
Table 2

Predictors of mortality among patients hospitalized for hypercalcemia of malignancy

Characteristics and complications

Odds ratio (95% confidence interval)

p value

Age

1.01 (1.00,1.02)

< 0.001

Sex (Female)

0.84 (0.77, 0.93)

0.001

Race

 White

Reference

 

 Black

0.89 (0.79, 1.00)

0.064

 Hispanic

0.93 (0.77, 1.12)

0.498

 Asian

1.21 (0.94, 1.57)

0.131

 Other

1.14 (0.88, 1.47)

0.294

Insurance

 Medicare

Reference

 

 Medicaid

1.08 (0.93, 1.26)

0.272

 Private

1.27 (1.13, 1.44)

< 0.001

 Self-pay/other

1.74 (1.46, 2.07)

< 0.001

Charlson comorbidity index

 < 3

Reference

 

 ≥ 3

1.06 (0.87, 1.29)

0.522

Type of facility

 Rural

Reference

 

 Urban non-teaching

0.84 (0.71, 0.99)

0.049

 Urban teaching

0.89 (0.76, 1.04)

0.156

Metastatic disease

1.73 (1.52, 1.97)

< 0.001

Protein calorie malnutrition

1.35 (1.22, 1.49)

< 0.001

Inpatient chemotherapy

0.72 (0.58, 0.89)

0.003

Mechanical ventilation

12.07 (10.50, 13.87)

< 0.001

Cardiopulmonary arrest

15.06 (8.62, 26.32)

< 0.001

Notes

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Hematology and Medical Oncology, James Graham Brown Cancer CenterUniversity of LouisvilleLouisvilleUSA
  2. 2.Division of Infectious DiseaseUniversity of LouisvilleLouisvilleUSA
  3. 3.Department of MedicineSinai Hospital of BaltimoreBaltimoreUSA
  4. 4.School of MedicineUniversity of LouisvilleLouisvilleUSA

Personalised recommendations